William Blair analyst Matt Phipps initiated coverage of NewAmsterdam Pharma with an Outperform rating.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NAMS:
William Blair analyst Matt Phipps initiated coverage of NewAmsterdam Pharma with an Outperform rating.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NAMS: